The in vitro activity of the tyrosine kinase inhibitor STI571 in BCR–ABL positive chronic myeloid leukaemia cells: synergistic interactions with anti-leukaemic agents
2002 ◽
Vol 86
(9)
◽
pp. 1472-1478
◽
2016 ◽
Vol 91
(11)
◽
pp. E480-E481
◽
2015 ◽
Vol 169
(5)
◽
pp. 683-688
◽
2013 ◽
Vol 20
(Suppl 1)
◽
pp. A4.3-A5
CP-214 Adherence to tyrosine kinase inhibitor treatments in chronic myeloid leukaemia: A pilot study
2016 ◽
Vol 23
(Suppl 1)
◽
pp. A94.2-A95
2015 ◽
Vol 2
(5)
◽
pp. e186-e193
◽